Emergent BioSolutions IncEmergent BioSolutions Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The Sustainability rating for Emergent BioSolutions Inc represents its reporting of the UN SDGs. The report of Emergent BioSolutions Inc leverages data from across the web as well as from available filings by Emergent BioSolutions Inc. Comprehensive Sustainability analysis of Emergent BioSolutions Inc can be accessed by signing in.

Emergent BioSolutions Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.9; made up of an environmental score of 0.0, social score of 0.0 and governance score of 2.7.

SDG Transparency Score for Emergent BioSolutions Inc 

0.9

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Emergent BioSolutions Inc 
0.0

Environmental

0.0

Social

2.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
.........
1810XBiotech Inc
1.1
Low
1826Mitsubishi Tanabe Pharma Corp
1.0
Low
1827Emergent BioSolutions Inc
0.9
Low
1827CannTrust Holdings Inc
0.9
Low
1827Cannabis Poland SA
0.9
Low
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Emergent BioSolutions Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc offer flexible work?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Emergent BioSolutions Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose water use targets?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Emergent BioSolutions Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Emergent BioSolutions Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Emergent BioSolutions Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose its waste policy?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose energy use targets?

LockedSign up for free to unlock

Does Emergent BioSolutions Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Emergent BioSolutions Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Emergent BioSolutions Inc
These potential risks are based on the size, segment and geographies of the company.

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Botulism Antitoxin Heptavalent to treat botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccine; raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to for inhalational anthrax; reactive skin decontamination lotion kits; and Trobigard, a combination drug-device auto injector product candidate; and Trobigard, a combination drug-device auto injector product candidate. The company also provides NARCAN, a nasal spray for the emergency treatment of known or suspected opioid overdose; Vivotif, an oral vaccine for typhoid fever; and Vaxchora, a single-dose oral vaccine to treat cholera. In addition, it is developing AP003, a Naloxone multidose nasal spray; AP007, a sustained release Nalmefene injection for treatment of opioid use disorder; AV7909, an anthrax vaccine; CGRD-001, a pralidoxime chloride/atropine auto-injector; CHIKV VLP, a chikungunya virus VLP vaccine; COVID-HIG for the treatment of SARS-CoV2; EGRD-001, a diazepam auto-injector; SIAN, an antidote for the initial treatment of acute poisoning of cyanide; and UniFlu, a universal influenza vaccine. Further, the company provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.

Sorry!

Failed to process!